Lindsay Dudgeon

A randomized single and multiple ascending dose study in healthy volunteers of LTI‐291, a centrally penetrant glucocerebrosidase activator

D. Hilt, M. D. de Kam, M. Moerland, 2021, British journal of clinical pharmacology.

A Phase 1B Trial in GBA1‐Associated Parkinson's Disease of BIA‐28‐6156, a Glucocerebrosidase Activator

N. Leymarie, D. Hilt, M. Moerland, 2023, Movement disorders : official journal of the Movement Disorder Society.